Investigating Biomarker Strategies for Patient Stratification for DDR Inhibitor Monotherapies
Time: 2:00 pm
day: Pre-Conference Day
Details:
• Review the predictive biomarkers that have been studied to identify patients most likely to respond to DDR inhibitor monotherapies
• Assess the validity and reproducibility of patient selection biomarkers for approved
monotherapies and apply these lessons to novel target monotherapies
• Reflect on the clinical relevance of biomarkers and concerns regarding tumor resistance
